ML

Medreich Limited

www.medreich.com link_icon

Market Research Report: Medreich Limited



Company Overview



  • Name: Medreich Limited

  • Mission: Finding innovative ways to meet our customer needs today and tomorrow.

  • Founded: 1976

  • Founders: No information is available

  • Key People:

  • Pankaj Garg, Group CEO and Managing Director

  • Gaurav Arora, Associate Vice President - Head of Procurement and Sourcing function | Leadership team

  • Sunil Bolar, Director Business Development Bluefish Pharmaceuticals

  • Pranab Moudgil, Vice President - Regulatory Affairs & Pharmacovigilance

  • Headquarters: Bengaluru, India

  • Number of Employees: Close to 4000

  • Revenue: No information is available

  • Known For: Contract Manufacturing and Development Organization (CMO & CDMO) business in pharmaceutical preparations in various dosage forms catering to diverse therapeutic categories. Medreich also has proficiency in developing formulations as patent non-infringing and niche generics in differentiated dosage forms for global markets.


Products



High-Level Description and Key Features of Products



Antibacterials


1. Amoxicillin
  • Formulations: Capsules 250mg, Capsules 500mg, Dispersible Tablets 250mg

  • Key Features: Effective antibacterial agent in capsule and tablet form.

2. Amoxicillin + Clavulanic acid
  • Formulations: Tablets 625mg, Tablets 1000mg

  • Key Features: Enhanced antibacterial effect due to combination with Clavulanic acid.

3. Cefotaxime Sodium
  • Formulations: Dry Powder for Injection 1000mg

  • Key Features: Injectable antibacterial formulation.


Antipsychotics


1. Aripiprazole
  • Formulations: Orodispersible Tablets (10mg, 15mg, 30mg), Tablets (5mg, 10mg, 15mg, 30mg)

  • Key Features: Orodispersible tablets for ease of administration; standard tablet formulations.


Antihypertensive


1. Atenolol + Nifedipine
  • Formulations: Capsules 50mg + 20mg

  • Key Features: Combination therapy for hypertension.

2. Bisoprolol
  • Formulations: Tablets (1.25mg, 2.5mg, 3.75mg, 5mg, 7.5mg, 10mg)

  • Key Features: Various dosage options for tailored hypertension management.


Analgesic and Antipyretic


1. Paracetamol
  • Formulations: Sustained Release Tablets 665mg, Capsules 500mg

  • Key Features: Standard and sustained-release formulations for pain and fever management.

2. Paracetamol + Codeine Phosphate
  • Formulations: Various combinations

  • Key Features: Combined analgesic effect for enhanced pain relief.


Anti-inflammatory


1. Ibuprofen
  • Formulations: Sustained Release Tablets 800mg, Tablets (200mg, 400mg, 600mg)

  • Key Features: Various dosage and release forms for anti-inflammatory and analgesic effects.


Recent Developments



1. New Partnerships:
  • FHC Farmaceutica, Portugal: Medreich has recently joined hands with FHC Farmaceutica.

2. Awards:
  • Medreich was awarded the Export Excellence Award.

3. Corporate Milestones:
  • Medreich became part of the Meiji Group, a leading Japanese conglomerate, in 2015.


Services and Capabilities



Proof of Concept


  • Offering novel drug delivery dosage form services through broad spectrum technology platforms. Recognized for speed, precision, and innovation.


Formulation Development


  • Expertise includes OSD (oral solid dosage forms), liquid syrups, emulsions, and semi-solid ointments and creams. Capabilities include various advanced granulation, compression, and filling technologies.


Analytical Services


  • Diverse expertise in analytical method development, validation, and technology transfer. Comprehensive capabilities include impurity profiling, solubility studies, dissolution method development, and stability studies.


Clinical Manufacturing


  • Provides cGMP manufacturing for bio batch products, including tablets and capsules. Conducts bioequivalence (BE) studies and partners with international CROs.


Commercial Manufacturing


  • Operates six state-of-the-art manufacturing facilities compliant with international regulatory and EHS standards. Equipped with advanced manufacturing and quality control systems.


Testimonials



  • Sanofi India Limited: Recognizes Medreich for its unparalleled support and dedication during the COVID-19 pandemic.

  • Berlin Pharma, Thailand: Recommends Medreich as a reliable, trustworthy partner in the pharmaceutical industry.




This report presents an information-dense overview of Medreich Limited, highlighting key aspects such as company profile, product offerings, recent developments, and capabilities based on available data.